Section Arrow
LNAI.NASDAQ
- Lunai Bioworks Inc.
Quotes are at least 15-min delayed:2026/06/25 06:32 EDT
Pre Market
Last
 3.5
+0.07 (+2.04%)
Bid
3.44
Ask
3.54
High 3.6 
Low 3.43 
Volume 3.09K 
Regular Hours (Closed)
Last
 3.43
-0.87 (-20.23%)
Day High 
4.4999 
Prev. Close
4.3 
1-M High
5.02 
Volume 
328.69K 
Bid
3.44
Ask
3.54
Day Low
3.3401 
Open
4.3 
1-M Low
2.02 
Market Cap 
19.50M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.11 
20-SMA 2.93 
50-SMA 2.66 
52-W High 212 
52-W Low 1.2104 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-61.52/--
Enterprise Value
19.92M
Balance Sheet
Book Value Per Share
-2.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0095-0.0322-77.22%-- 
Pre Market -- -- --
CALCCalciMedica0.5973-0.206-25.64%-- 
Pre Market 0.57 -0.0273 -4.57%
ABSIAbsci Corp10.075+2.665+35.96%-- 
Pre Market 10.03 -0.045 -0.45%
EVGNEvogene Ltd.0.4392-0.0518-10.55%-- 
Pre Market 0.424 -0.0152 -3.46%
HUMAHumacyte0.6977-0.0027-0.39%-- 
Pre Market 0.71 +0.0123 +1.76%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics toprovide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.